A further 327 hospital-dispensed medicines will also drop in price from the start of 2018.
About 80% of the drugs are all different brand names of 10 active ingredients, according to the General Council of the Official College of Pharmacists.
These include Salbutamol, used to treat asthma – a medication taken by Vuelta a España and Tour de France winner Chris Froome and which has led to his failing a drug test, a verdict currently under appeal.
The tetracyclic antidepressant Mirtazapine, a version which creates a calming and appetite-enhancing effect and is used to treat anxiety, is on the list as well as the antibiotic Azithromycin, Chondroitin Sulfate – often sold as Glucosamine – used to ease the effects of arthritis, and the contraceptive Ethinylestradiol, also known as Levonorgestrel.
Two medications for arterial hypertension – Candesartan-Hydrochlorothiazide, also known as used for treating water retention in patients with congestive heart failure, liver cirrhosis or kidney disorders, and Olmesartan Medoxomil, for treating high blood pressure, will go down in price.
The immune system suppressant Methotrexate, used for cancer, ectopic pregnancy, rheumatoid arthritis and autoimmune diseases; Latanoprost, often sold as Xalatan, used to treat glaucoma; and Insulin Glargine, to treat diabetes, are the final three which will become cheaper in January.
From January 1, any of these drugs already in stock will be sold at the new lower prices and pharmacies will bear the cost difference.